Nisa Investment Advisors
LXEO icon

Nisa Investment Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Nisa Investment Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9K Buy
4,865
+2,100
+76% +$14.9K ﹤0.01% 1892
2025
Q4 		$27.5K Hold
2,765
– – ﹤0.01% 1821
2025
Q3 		$18.4K Hold
2,765
– – ﹤0.01% 2044
2025
Q2 		$11.1K Buy
2,765
+2,426
+716% +$7.98K ﹤0.01% 2213
2025
Q1 		$1.18K Sell
339
-57
-14% -$253 ﹤0.01% 2595
2024
Q4 		$2.61K Buy
+396
New +$3.12K ﹤0.01% 2410
2024
Q3 		– Sell
-32
Closed -$513 – 3011
2024
Q2 		$513 Buy
+32
New +$465 ﹤0.01% 2678

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nisa Investment Advisors's LXEO Position: Q1 2026 in Review

Nisa Investment Advisors increased its Lexeo Therapeutics (LXEO) stake by 76% in Q1 2026, buying an estimated $14.9K and bringing the position to 4,865 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Nisa Investment Advisors first reported a position in LXEO in Q2 2024 and has held it in 7 quarters since. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Nisa Investment Advisors held 4,865 shares of Lexeo Therapeutics worth $27.9K as of Q1 2026.
  • Nisa Investment Advisors bought 2,100 Lexeo Therapeutics shares in Q1 2026, an estimated $14.9K.
  • Lexeo Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1892 holding.
  • Nisa Investment Advisors first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.